Transcriptional regulation by a DNA-associated form of cyclin D1

Frédéric Bienvenu1, Benjamin Barré, Sandrine Giraud

  • 1INSERM U564, Cancer Center Paul Papin, Angers, France.

Insights

Cyclin D1 binds to the p21 gene promoter, inhibiting its expression. This transcriptional role of cyclin D1 is crucial for regulating cell cycle genes and may contribute to cell transformation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cyclin D1 is a key cell cycle regulator.
  • Cyclin D1 also interacts with transcription factors to modulate gene expression.

Purpose of the Study:

  • To investigate the mechanism by which cyclin D1 regulates gene transcription.
  • To determine the role of cyclin D1 in the regulation of the p21waf1 gene.

Main Methods:

  • Chromatin immunoprecipitation assays to detect protein-DNA interactions.
  • RNA interference (siRNA) to down-regulate cyclin D1 expression.
  • Analysis of p21waf1 gene expression in cyclin D1 deficient cells and cancer cells.

Main Results:

  • Cyclin D1 is recruited to the p21waf1 promoter via a STAT3-NcoA complex.
  • Cyclin D1 binding to DNA inhibits the recruitment of CBP histone acetylase and RNA polymerase II.
  • p21waf1 gene expression is increased in cyclin D1 knockout cells or upon cyclin D1 knockdown.
  • STAT3-mediated activation of p21waf1 is suppressed in breast cancer cells with high cyclin D1 levels.

Conclusions:

  • Cyclin D1 possesses transcriptional regulatory functions that inhibit p21waf1 gene expression.
  • These transcriptional activities of cyclin D1 are important for cell cycle gene regulation.
  • The transcriptional role of cyclin D1 may be implicated in cellular transformation and cancer development.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...